1	Flutamide	Flutamide	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	treatment	treatment	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	hirsutism	hirsutism	_	_	_	_	_	_	_
7	:	:	_	_	_	_	_	_	_
8	long-term	long-term	_	_	_	_	_	_	_
9	clinical	clinical	_	_	_	_	_	_	_
10	effects	effect	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	endocrine	endocrine	_	_	_	_	_	_	_
13	changes	change	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	androgen	androgen	_	_	_	_	_	_	_
17	receptor	receptor	_	_	_	_	_	_	_
18	behavior	behavior	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	To	to	_	_	_	_	_	_	_
4	investigate	investigate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	long-term	long-term	_	_	_	_	_	_	_
7	effects	effect	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	treatment	treatment	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	low	low	_	_	_	_	_	_	_
12	doses	dose	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	flutamide	flutamide	_	_	_	_	_	_	_
15	on	on	_	_	_	_	_	_	_
16	clinical	clinical	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	hormonal	hormonal	_	_	_	_	_	_	_
19	parameters	parameter	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	well	well	_	_	_	_	_	_	_
23	as	as	_	_	_	_	_	_	_
24	on	on	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	androgen	androgen	_	_	_	_	_	_	_
27	receptor	receptor	_	_	_	_	_	_	_
28	status	status	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	hirsute	hirsute	_	_	_	_	_	_	_
32	women	woman	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	DESIGN	design	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Eighteen	eighteen	_	_	_	_	_	_	_
4	hirsute	hirsute	_	_	_	_	_	_	_
5	patients	patient	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	regular	regular	_	_	_	_	_	_	_
8	menses	mens	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	studied	study	_	_	_	_	_	_	_
11	basally	basally	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	during	during	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	125	125	_	_	_	_	_	_	_
17	mg	mg	_	_	_	_	_	_	_
18	flutamide	flutamide	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	three	three	_	_	_	_	_	_	_
21	times	time	_	_	_	_	_	_	_
22	per	per	_	_	_	_	_	_	_
23	day	day	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	12	12	_	_	_	_	_	_	_
26	months	month	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Barrier	Barrier	_	_	_	_	_	_	_
2	or	or	_	_	_	_	_	_	_
3	intrauterine	intrauterine	_	_	_	_	_	_	_
4	contraception	contraception	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	study	study	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	sexually	sexually	_	_	_	_	_	_	_
12	active	active	_	_	_	_	_	_	_
13	women	woman	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Safety	Safety	_	_	_	_	_	_	_
2	parameters	parameter	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	assessed	assess	_	_	_	_	_	_	_
5	throughout	throughout	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	study	study	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Hirsutism	Hirsutism	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	graded	grade	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	modified	modify	_	_	_	_	_	_	_
7	Ferriman-Gallwey	ferriman-gallwey	_	_	_	_	_	_	_
8	score	score	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	hormonal	hormonal	_	_	_	_	_	_	_
12	parameters	parameter	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	evaluated	evaluate	_	_	_	_	_	_	_
15	basally	basally	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	at	at	_	_	_	_	_	_	_
18	4-month	4-month	_	_	_	_	_	_	_
19	intervals	interval	_	_	_	_	_	_	_
20	during	during	_	_	_	_	_	_	_
21	treatment	treatment	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Gonadotropin-releasing	gonadotropin-releasing	_	_	_	_	_	_	_
2	hormone	hormone	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	ACTH	acth	_	_	_	_	_	_	_
5	stimulation	stimulation	_	_	_	_	_	_	_
6	tests	test	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	performed	perform	_	_	_	_	_	_	_
9	before	before	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	after	after	_	_	_	_	_	_	_
12	3	3	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	4	4	_	_	_	_	_	_	_
15	months	month	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	therapy	therapy	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	concentration	concentration	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	androgen	androgen	_	_	_	_	_	_	_
8	receptors	receptor	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	mononuclear	mononuclear	_	_	_	_	_	_	_
11	leukocytes	leukocyte	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	measured	measure	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	both	both	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	follicular	follicular	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	luteal	luteal	_	_	_	_	_	_	_
21	phases	phase	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	menstrual	menstrual	_	_	_	_	_	_	_
25	cycle	cycle	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	basally	basally	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	after	after	_	_	_	_	_	_	_
30	4	4	_	_	_	_	_	_	_
31	months	month	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	flutamide	flutamide	_	_	_	_	_	_	_
34	treatment	treatment	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Flutamide	Flutamide	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	well	well	_	_	_	_	_	_	_
6	tolerated	tolerate	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	all	all	_	_	_	_	_	_	_
9	women	woman	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	noticeable	noticeable	_	_	_	_	_	_	_
14	exception	exception	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	one	one	_	_	_	_	_	_	_
17	patient	patient	_	_	_	_	_	_	_
18	who	who	_	_	_	_	_	_	_
19	presented	present	_	_	_	_	_	_	_
20	increased	increase	_	_	_	_	_	_	_
21	serum	serum	_	_	_	_	_	_	_
22	transaminase	transaminase	_	_	_	_	_	_	_
23	after	after	_	_	_	_	_	_	_
24	8	8	_	_	_	_	_	_	_
25	months	month	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	therapy	therapy	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Hirsutism	Hirsutism	_	_	_	_	_	_	_
2	markedly	markedly	_	_	_	_	_	_	_
3	improved	improve	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	all	all	_	_	_	_	_	_	_
6	women	woman	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	treatment	treatment	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	Ferriman-Gallwey	ferriman-gallwey	_	_	_	_	_	_	_
12	score	score	_	_	_	_	_	_	_
13	after	after	_	_	_	_	_	_	_
14	1	1	_	_	_	_	_	_	_
15	year	year	_	_	_	_	_	_	_
16	:	:	_	_	_	_	_	_	_
17	4.1	4.1	_	_	_	_	_	_	_
18	+/-	+/-	_	_	_	_	_	_	_
19	0.5	0.5	_	_	_	_	_	_	_
20	versus	versus	_	_	_	_	_	_	_
21	14.1	14.1	_	_	_	_	_	_	_
22	+/-	+/-	_	_	_	_	_	_	_
23	0.9	0.9	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	reduction	reduction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	serum	serum	_	_	_	_	_	_	_
5	androgens	androgen	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	found	find	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	whereas	whereas	_	_	_	_	_	_	_
10	no	no	_	_	_	_	_	_	_
11	change	change	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	observed	observe	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	either	either	_	_	_	_	_	_	_
16	basal	basal	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	GnRH-stimulated	gnrh-stimulated	_	_	_	_	_	_	_
19	gonadotropins	gonadotropin	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	cortisol	cortisol	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	17	17	_	_	_	_	_	_	_
26	alpha-hydroxyprogesterone	alpha-hydroxyprogesterone	_	_	_	_	_	_	_
27	response	response	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	ACTH	ACTH	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Cycles	cycle	_	_	_	_	_	_	_
2	remained	remain	_	_	_	_	_	_	_
3	ovulatory	ovulatory	_	_	_	_	_	_	_
4	.	.	_	_	_	_	_	_	_

1	Before	before	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	number	number	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	androgen	androgen	_	_	_	_	_	_	_
8	receptors	receptor	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	higher	high	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	luteal	luteal	_	_	_	_	_	_	_
14	than	than	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	follicular	follicular	_	_	_	_	_	_	_
18	phase	phase	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	rhythmic	rhythmic	_	_	_	_	_	_	_
3	differentiation	differentiation	_	_	_	_	_	_	_
4	disappeared	disappear	_	_	_	_	_	_	_
5	after	after	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	patients	patient	_	_	_	_	_	_	_
8	had	have	_	_	_	_	_	_	_
9	been	be	_	_	_	_	_	_	_
10	given	give	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	antiandrogen	antiandrogen	_	_	_	_	_	_	_
13	drug	drug	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Flutamide	Flutamide	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	effective	effective	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	treatment	treatment	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	hirsutism	hirsutism	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	requires	require	_	_	_	_	_	_	_
13	constant	constant	_	_	_	_	_	_	_
14	surveillance	surveillance	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	liver	liver	_	_	_	_	_	_	_
17	function	function	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Androgen	Androgen	_	_	_	_	_	_	_
2	receptor	receptor	_	_	_	_	_	_	_
3	blockade	blockade	_	_	_	_	_	_	_
4	might	might	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	potentiated	potentiate	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	reduction	reduction	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	serum	serum	_	_	_	_	_	_	_
12	androgens	androgen	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Flutamide	Flutamide	_	_	_	_	_	_	_
2	affects	affect	_	_	_	_	_	_	_
3	androgen	androgen	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	behavior	behavior	_	_	_	_	_	_	_
6	during	during	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	menstrual	menstrual	_	_	_	_	_	_	_
9	cycle	cycle	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	meaning	meaning	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	finding	finding	_	_	_	_	_	_	_
6	remains	remain	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	elucidated	elucidate	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

